Methyltestosterone
- Generic Name
- Methyltestosterone
- Brand Names
- Covaryx, Methitest
- Drug Type
- Small Molecule
- Chemical Formula
- C20H30O2
- CAS Number
- 58-18-4
- Unique Ingredient Identifier
- V9EFU16ZIF
- Background
A synthetic anabolic steroid used for treating men with testosterone deficiency or similar androgen replacement therapies. Also, has antineoplastic properties and so has been used secondarily in women with advanced breast cancer. Methyltestosterone is a schedule III drug in the US.
- Indication
Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency. It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause.
- Associated Conditions
- Hypergonadotropic Hypogonadism, Idiopathic Hypogonadotropic Hypogonadism, Metastatic Breast Cancer, Puberty, Delayed, Testosterone Deficiency
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
- Conditions
- Hot Flushes, Menopause, Postmenopause
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-08-15
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 1251
- Registration Number
- NCT00160342
- Locations
- 🇺🇸
Site 42, Virginia Beach, Virginia, United States
🇺🇸Site 14, Waterbury, Connecticut, United States
🇺🇸Site 4, Groton, Connecticut, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
- Conditions
- Menopause
- Interventions
- Drug: Esterified estrogens 1.25 mg
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 133
- Registration Number
- NCT00141557
- Locations
- 🇺🇸
Site 49, Melbourne, Florida, United States
🇺🇸Site 44, Decatur, Georgia, United States
🇺🇸Site 37, Reno, Nevada, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
- Conditions
- Menopause
- Interventions
- Drug: Esterified estrogens 1.25 mg
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT00141544
- Locations
- 🇺🇸
Site 57, Mobile, Alabama, United States
🇺🇸Site 78, Clearwater, Florida, United States
🇺🇸Site 65, Cary, North Carolina, United States
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
- Conditions
- Menopause
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 350
- Registration Number
- NCT00141570
- Locations
- 🇺🇸
Site 41, Medford, Oregon, United States
🇺🇸Site 60, Columbus, Ohio, United States
🇺🇸Site 49, Melbourne, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.